1
Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis
Condition(s):Multiple Sclerosis; Internuclear OphthalmoplegiaLast Updated:September 23, 2022Recruiting
Clemastine as an Intervention: 16 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Condition(s):Multiple Sclerosis (MS); Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis, Primary Progressive; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis Relapse; Multiple Sclerosis Brain Lesion; Multiple Sclerosis BenignLast Updated:May 10, 2023Not yet recruiting
3
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Condition(s):Optic NeuritisLast Updated:May 10, 2023Recruiting
4
Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:October 18, 2021Completed
5
Clemastine in Cardiovascular Surgery
Condition(s):Efficacy and SafetyLast Updated:January 13, 2020Completed
6
Effect of Clemastine Fumarate on Color Vision in Healthy Controls
Condition(s):Healthy SubjectsLast Updated:November 3, 2016Completed
7
CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy
Condition(s):Multiple SclerosisLast Updated:May 1, 2023Recruiting
8
To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
Condition(s):AllergyLast Updated:March 28, 2017Completed
9
Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
Condition(s):Allergy; DermatitisLast Updated:January 28, 2011Unknown status
10
Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis
Condition(s):DermatitisLast Updated:November 3, 2022Withdrawn